Public list: Pharma Startups (6570) Neuroscience Startups (947)
Keapstone Therapeutics is developing a series of small molecule activators of the Nrf2-ARE pathway for neuroprotection in Parkinson's and amyotrophic lateral sclerosis (ALS).
Company (Alive / Active)
Phone: 0114 222 4330
The Sheffield Bioincubator
40 Leavygreave Road
Sheffield, S3 7RD
England, United Kingdom
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Title | Application Date | Patent Date | Status (Patent / Application) |
---|